Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Leonardo Seoane, Marcia Cortés, María Esther Aris Cancela, Juan Furmento, Adrián Baranchuk & Diego Conde. (2018) Rivaroxaban in the cardiovascular world: a direct anticoagulant useful to prevent stroke and venous and arterial thromboembolism. Expert Review of Cardiovascular Therapy 16:7, pages 501-514.
Read now
Read now
Shant Shirvanian & Victor F. Tapson. (2015) Venous thromboembolism: identifying patients at risk and establishing prophylaxis. Current Medical Research and Opinion 31:12, pages 2297-2311.
Read now
Read now
A John Camm, Pierre Amarenco, Sylvia Haas, Susanne Hess, Paulus Kirchhof, Martin van Eickels & Alexander GG Turpie. (2014) XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation. Vascular Health and Risk Management 10, pages 425-434.
Read now
Read now
Saleh Rachidi, Ehab Saad Aldin, Charles Greenberg, Barton Sachs, Michael Streiff & Amer M Zeidan. (2013) The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery. Expert Review of Hematology 6:6, pages 677-695.
Read now
Read now
Articles from other publishers (1)
Giovanni Improta, Giovanni Balato, Carlo Ricciardi, Mario Alessandro Russo, Ida Santalucia, Maria Triassi & Mario Cesarelli. (2019) Lean Six Sigma in healthcare. The TQM Journal 31:4, pages 526-540.
Crossref
Crossref